Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Evaluation of Hypofractionated Breast Irradiation in Patients Undergoing Standard Lumpectomy or Oncolytic Mammoplasty With Bilateral Breast Reduction

NCT01400399 is registered in ClinicalTrials.gov with Coastal Carolina Radiation Oncology as lead sponsor.

NCT NCT01400399
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400399 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Evaluation of Hypofractionated Breast Irradiation in Patients Undergoing Standard Lumpectomy or Oncolytic Mammoplasty With Bilateral Breast Reduction
Lead sponsor
Coastal Carolina Radiation Oncology
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2010
Completion date
August 31, 2020
Enrollment
84 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma